Rapid digitalization, organizations’ increasing tech budgets, and continuing tech innovations should propel the tech market’s growth in 2022. Therefore, we believe it may be rewarding to invest in tech stocks Intuit (INTU), Constellation Software (CNSWF), and Veeva Systems (VEEV). These names are currently trading below their 52-week highs primarily because of the concerns surrounding expected interest rate hikes. Read on.

shutterstock.com – StockNews

Although many technology stocks have tumbled in price since the beginning of the year on investors’ concerns over expected interest rate hikes, 2022 is expected to be a year of normalization for the technology sector, with an acceleration of digitization across the global economy. According to Forrester’s U.S. Tech Market Outlook, U.S. tech spending is expected to expand by 6.7% in 2022.

Furthermore, an increasing dependency on cloud services and the growing popularity of wireless infrastructure should boost the industry’s growth. Investors’ interest in tech stocks is evident in the Technology Select Sector SPDR Fund’s (XLK) 23.6% gains over the past year.

Given this backdrop, we think it could be wise to bet on quality tech stocks Intuit Inc. (INTU), Constellation Software Inc. (CNSWF), and Veeva Systems Inc. (VEEV), which are currently trading below their 52-weeks highs.

Intuit Inc. (INTU)

Mountain View, Calif.-based INTU is a global technology platform that provides financial management and compliance products and services in the United States, Canada, and internationally. The company operates in Small Business & Self-Employed; Consumer; Credit Karma; and ProConnect segments. Its professional tax offerings include Lacerte, ProSeries, ProFile, and ProConnect Tax Online.

This month, INTU announced its “Early Start” campaign, which is the U.S. and Canadian QuickBooks campaign. This integrated campaign is designed to demonstrate that small start-up businesses can manage critical business operations, thus helping them grow and succeed.

During its fiscal first quarter, ended Oct. 31, 2021, INTU’s total net revenue increased 51.7% year-over-year to $2.01 billion. The company’s operating income came in at $195 million. Its net income grew 15.2% from its year-ago value to $228 million. Also, the company’s EPS rose 9.3% from the prior-year quarter to $0.82.

INTU’s revenue is expected to increase 27.4% year-over-year to $12.27 billion in its fiscal year 2022. Also, its EPS is expected to increase 20.1% in fiscal 2021 and 15.2% in fiscal 2022. The stock has gained 41.7% in price over the past year. It is currently trading 23.9% below its 52-week high of $716.86, which it hit on Nov.15, 2021.

INTU’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which equates to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 distinct factors, each with its own weighting.

Also, the stock has an A grade for Quality and a B grade for Growth and Sentiment. We have also graded INTU for Value, Stability, and Momentum. Click here to access all INTU’s ratings. INTU is ranked #22 of 166 stocks in the Software – Application industry.

Constellation Software Inc. (CNSWF)

Headquartered in Toronto, Canada, CNSWF is a global provider of market-leading software and services to several industries. The company operates through Public- Sector and Private-Sector segments. CNSWF serves government and government-related customers, as well as commercial customers.

In November 2021, CNSWF created a $200 million venture capital fund. The fund is meant to provide financing for start-up and rapidly growing vertical market software businesses, most of which will have been either incubated or identified by a sponsoring CNSWF business unit.

CNSWF’s revenue increased 29.5% year-over-year to $1.3 billion in the third quarter, ended Sept. 30, 2021. The company’s net income came in at $121 million, and its EPS came in at $5.04 for the period.

CNSWF’s consensus revenue is expected to be 1.42 billion, increasing 20.5% year-over-year for its fiscal period ending March 2022. The stock has gained 28.3% in price  over the past year. It is trading 13.9% below its 52-week high of $1,919.99, which it hit on Jan. 3, 2022.

CNSWF’s POWR Ratings reflect this promising outlook. The stock has an overall B rating, which equates to a Buy in our proprietary rating system. Also, the stock has an A grade for Stability B grade for Quality.

In addition to the POWR Rating grades I have just highlighted, one can see CNSWF’s ratings for Momentum, Value Sentiment, and Growth here. CNSWF is ranked #23 in the Software – Application industry.

Click here to check out our Software Industry Report

Veeva Systems Inc. (VEEV)

Incorporated in 2007, VEEV provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The Pleasanton, Calif., company’s solutions include cloud software, data, and business consulting. VEEV’s industry cloud solutions for the life sciences industry are grouped into two product areas: Veeva Commercial Cloud and Veeva Vault.

This month, PharmaEssentia, a biotechnology company, has adopted VEEV’s data cloud to support the launch of BESREMi, a new therapy for polycythemia vera (PV), a rare blood cancer. With the data cloud, VEEV could support PharmaEssentia with multiple commercial analytics and operations workflows so the company can better educate key HCPs on its important new treatment option.

For its  fiscal third quarter, ended Oct. 31, 2021, VEEV’s total revenues increased 26.1% year-over-year to $476.11 million. The company’s gross profit grew 26.2% from its year-ago value to $346.55 million. Its operating income rose 31% from the prior-year quarter to $132.71 million. Also, the company’s net income increased 9.2% year-over-year to $105.87 million.

VEEV’s revenue is expected to increase 26.1% year-over-year to $1.85 billion in its fiscal year 2022. The company has an impressive earnings surprise history; it beat the consensus EPS estimates in each of the trailing four quarters. Its EPS is expected to increase 25.5% in fiscal 2021 and 8.1% in fiscal 2022. The stock is currently trading 36% below its 52-week high of $343.96, which it hit on August 5, 2021.

It is no surprise that VEEV has an overall B rating, which equates to a Buy in our POWR Rating system. Also, the stock has an A grade for Quality and a B grade for Sentiment and Growth.

Click here to see the additional POWR Ratings for VEEV (Value, Stability, and Momentum). The stock is ranked #23 of 87 in the Medical – Services industry.

INTU shares rose $7.03 (+1.29%) in premarket trading Thursday. Year-to-date, INTU has declined -15.12%, versus a -4.89% rise in the benchmark S&P 500 index during the same period.

About the Author: Priyanka Mandal

Priyanka is a passionate investment analyst and financial journalist. After earning a master’s degree in economics, her interest in financial markets motivated her to begin her career in investment research.

More…

The post 3 Tech Stocks to Buy at a Discount appeared first on StockNews.com

https://www.entrepreneur.com/article/414142

Rising inflation and concerns surrounding potential interest rate hikes caused the major stock market indexes to retreat in the first week of this year. However, a decline in the unemployment rate and the expectation of a solid fourth-quarter earnings season should help the market see an uptrend in the near term. Thus, we think it could be wise to bet on low-priced stocks SunCoke (SXC), Lincoln Educational Services (LINC), and Destination XL Group (DXLG), which we think hold immense upside potential. Read on.

shutterstock.com – StockNews

Although market turbulence continued last week on speculation surrounding interest rate hikes and rising inflation, the U.S. stock market is expected to perform strongly in the coming months. While only a few companies have released their fourth-quarter earnings reports so far, a FactSet report estimates the earnings growth rate for S&P 500 members to be 21.7% for the quarter.

Furthermore, the labor market is expected to hit full employment this year. The unemployment rate decreased to 3.9% at year’s end from 6.3% in January 2021.

Therefore, we think fundamentally strong stocks SunCoke Energy, Inc. (SXC), Lincoln Educational Services Corporation (LINC), and Destination XL Group, Inc. (DXLG), which are currently trading at less than $10, could deliver solid upside in the coming months.

SunCoke Energy, Inc. (SXC)

SXC in Lisle, Ill., is a raw material processing and handling company. It serves steel and power customers, with its principal business cokemaking and logistics. The company operates through three segments: Domestic Coke; Brazil Coke; and Logistics. Additionally, SXC owns and operates five cokemaking facilities in the United States and one in Brazil.

SXC’s revenues increased 21.3% year-over-year to $366.5 million in the third quarter, ended Sept. 30, 2021. The company’s operating income rose 245% from the prior-year quarter to $41.4 million. Its net income came in at $23 million, compared to a $2.7 million net loss in the prior-year quarter. Also, the company’s EPS amounted to $0.27, compared to a $0.03 loss per share in the third quarter of 2020.

SXC has an impressive earnings surprise history; it beat the consensus EPS estimates in three of the trailing four quarters. SXC’s EPS is estimated to grow at an 8% CAGR per annum over the next five years. The stock has gained 13.1% in price over the past month and 30.1% over the past year to close its last trading session at $7.52.

SXC’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall A rating, which equates to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 distinct factors, each with its own weighting.

Also, the stock has an A grade for Growth and Momentum. We have also graded SXC for Quality, Value, Sentiment, and Stability. Click here to access all SXC’s ratings. SXC is ranked #1 of 11 stocks in the B-rated Coal industry.

Lincoln Educational Services Corporation (LINC)

LINC in West Orange, N.J. provides diversified career-oriented post-secondary education to high school graduates and working adults. Transportation and Skilled Trades; Healthcare and Other Professions; and Transitional are the company’s operational segments. LINC operates 22 schools in 14 states under Lincoln Technical Institute, Lincoln College of Technology, Lincoln Culinary Institute, Euphoria Institute of Beauty Arts and Sciences, and associated brand names.

Last month, LINC’s South Plainfield, N.J. campus welding program was granted accreditation by the National Center for Construction Education & Research (NCCER). The company believes that this recognition proves that LINC’s curriculum and training methodologies help students prepare to step into the workforce immediately.

During the third quarter, ended Sept. 30, 2021, LINC’s revenue increased 13% year-over-year to $89.06 million. The company’s operating income grew 49.6% from its year-ago value to $5.75 million. Its net income rose 9.3% from the prior-year quarter to $3.84 million. Also, the company’s EPS increased 37.5% year-over-year to $0.11.

LINC’s revenue is expected to increase 4.6% year-over-year to $349.55 million in its fiscal year 2022. In addition, the company has an impressive earnings surprise history; it beat the consensus EPS estimates in each of the trailing four quarters. Furthermore, its EPS is expected to increase 113.9% in fiscal 2021. Closing yesterday’s trading session at $6.86, the stock has soared 6.4% in price over the past nine months and 11.5% over the past year.

LINC’s POWR Ratings reflect this promising outlook. The stock has an overall A rating, which equates to a Strong Buy in our proprietary rating system. Also, the stock has an A grade for Value and Sentiment.

In addition to the POWR Rating grades I’ve just highlighted, one can see LINC’s ratings for Growth, Stability, Quality, and Momentum here. The stock is ranked #1 of 23 stocks in the Outsourcing – Education Services industry.

Note that LINC is one of the few stocks handpicked by our Chief Growth Strategist, Jaimini Desai, currently in the POWR Stocks Under $10 portfolio. Learn more here.

Destination XL Group, Inc. (DXLG)

Incorporated in 1976, DXLG is a specialty retailer of big and tall men’s clothing and shoes with retail, wholesale and direct operations in the United States and Toronto, Canada. The Canton, Mass.-based company offers sportswear, accessories, casual clothing, tailored-related separates, blazers, dress slacks, and woven under various private labels. Polo Ralph Lauren, Lacoste, Levi’s, Nautica, Reebok, and vineyard vines are brands carried by DXLG.

This month, DXLG partnered with Nautica, the global designer of sportswear and lifestyle brand vineyard vines brands, to launch the Big + Tall apparel space, starting with the Spring 2022 season. This partnership should offer a wide range of designer Big + Tall clothes to DXLG’s customers.

DXLG’s sales increased 42.6% year-over-year to $121.49 million for its fiscal third quarter, ended Oct. 30, 2021. The company’s gross profit grew 96.2% from its year-ago value to $60.96 million. Its operating income came in at $15.94 million, versus a $5.92 million operating loss in the prior-year quarter. Also, the company’s net income amounted to $13.66 million, compared to a $7.02 million net loss in its fiscal third quarter of 2020.

For its fiscal 2022, DXLG’s revenue is expected to be $503.35 million, representing a 57.8% year-over-year increase. Its EPS is expected to increase 15% per annum in the next five years. Closing its last trading session at $5.04, the stock has surged 235.3% in price over the past nine months and 1,160% over the past year.

It is no surprise that DXLG has an overall A rating, which equates to a Strong Buy in our POWR Rating system. Also, the stock has an A grade for Growth, Sentiment, and Quality.

Click here to see the additional POWR Ratings for DXLG (Value, Stability, and Momentum). DXLG is ranked #1 of 46 stocks in the B-rated Specialty Retailers industry.

Note that DXLG is one of the few stocks handpicked by our Chief Growth Strategist, Jaimini Desai, currently in the POWR Stocks Under $10 portfolio. Learn more here.

SXC shares were unchanged in premarket trading Thursday. Year-to-date, SXC has gained 14.11%, versus a -4.89% rise in the benchmark S&P 500 index during the same period.

About the Author: Priyanka Mandal

Priyanka is a passionate investment analyst and financial journalist. After earning a master’s degree in economics, her interest in financial markets motivated her to begin her career in investment research.

More…

The post 3 Stocks Under $10 With Major Potential in 2022 appeared first on StockNews.com

https://www.entrepreneur.com/article/414124

Renalytix AI PLC Sponsored ADR (RNLX) shares soared 10.4% in the last trading session to close at $15.45. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock’s 9.4% loss over the past four weeks.

– Zacks

The stock scored a strong price increase driven by the optimism surrounding the company’s latest publication of favorable study results for KidneyIntelX in The American Journal of Nephrology. The study results show that risk assessment and monitoring with KidneyIntelX can support primary care physicians and deliver proactive therapeutic management in early-stage diabetic kidney disease. The market is also upbeat about the Renalytix’s recent collaboration with Singing River Health System intended to deploy KidneyIntelX informed care management to enhance kidney health in individuals with type 2 diabetes and early-stage chronic kidney disease.

This company is expected to post quarterly loss of $0.18 per share in its upcoming report, which represents a year-over-year change of -50%. Revenues are expected to be $1.55 million, up 287.5% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For Renalytix AI PLC Sponsored ADR, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock’s price usually doesn’t keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on RNLX going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

As one investor put it, “curing and preventing hundreds of diseases…what should that market be worth?” This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Renalytix AI PLC Sponsored ADR (RNLX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

https://www.entrepreneur.com/article/414132

Nu Skin Enterprises, Inc. NUS appears to be in robust shape. Its focus on empowering sales leaders and strengthening the customer base, with effective product launches and engaging technology platforms, has been working well for the company. These factors keep Nu Skin well-placed amid challenges related to COVID-19.

– Zacks

Focus on Product Launches – a Long-Term Strategy

The company’s long-term strategies stand on three key pillars: Products, Programs and Platforms. The launch of NUS’ revolutionary ageLOC LumiSpa, along with the re-launch of the Galvanic Spa device, has been a success. Management is also impressed with the rollout of Nutricentials Bioadaptives, a customizable skincare line targeted at millennials and Gen Z. In a recent update, management highlighted that it is impressed with the launch of Collagen+ in the United States amid pandemic-inflicted disruptions. In the third quarter, the company’s top line partly benefited from continued growth in the United States due to the Beauty Focus Collagen+ launch. The company stated that it will focus on expanding ageLOC META and Collagen+ across markets during the fourth quarter. Apart from product launches, Nu Skin’s well-knit product strategies and customer retention programs have been driving growth in several market locations.

Image Source: Zacks Investment Research

Empowering Sales Leaders & Solidifying Customer Base

Nu Skin sells and distributes products through a network of sales leaders and customers. The company remains focused on empowering them through product launches and engaging technology platforms among other initiatives. Moreover, the company has been conducting several promotional seminars online. Additionally, Nu Skin rolled out its Velocity sales compensation plan as well as the enJoy rewards program over the past three years. These programs are doing well and continuing to aid growth in sales leaders and customers. The company is also expanding the social commerce training for its leaders. During the third quarter of 2021, the company benefited from double-digit growth in Korea, driven by product promotions and sales leader initiatives.
A shift to work-from-home and at-home personal care trends has led to increased online shopping, which presents a unique opportunity for the company’s business. With these macro trends, Nu Skin is making significant investments in the digital platform to build a socially enabled business. NUS is on track to become a disruptive beauty and wellness leader via three key transformational strategies. The company is developing innovative products and leveraging its key position in beauty device systems. It is planning to launch next-generation connected devices beginning in 2022. Further, management is transforming its business with the help of robust social commerce and distinctive person-to-person affiliate marketing channel for creating more brand awareness as well as acquiring customers at a higher rate. Lastly, the company’s focus on building a robust digital ecosystem to enhance customer attraction bodes well. The digital platform accounts for more than 90% of the company’s revenues.
Nu Skin is set to keep its splendid show going with its abovementioned growth endeavors. This Zacks Rank #2 (Buy) stock has rallied 28.5% in the past three months compared with the industry’s rise of 1.1%.

Hot Consumer Staple Bets

Some other top-ranked stocks are Helen of Troy HELE, The Estee Lauder Companies Inc. EL and Medifast, Inc. MED
Helen of Troy, a designer, developer, marketer, importer and distributor, carries a Zacks Rank #1 (Strong Buy) at present. Shares of Helen of Troy have dipped 1.1% in the past three months. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Helen of Troy’s current financial-year sales and earnings per share (EPS) suggests growth of 0.8% and 0.6%, respectively, from the year-ago reported number. HELE has a trailing four-quarter earnings surprise of 19.1%, on average.
The Estee Lauder Companies, which manufactures, markets and sells skincare, makeup, fragrance and hair care products, carries a Zacks Rank #2 at present. Shares of The Estee Lauder Companies have moved up 2.2% in the past three months.
The Zacks Consensus Estimate for The Estee Lauder Companies’ current financial-year sales and EPS suggests growth of 15.5% and 15.2%, respectively, from the year-ago reported number. EL has a trailing four-quarter earnings surprise of 37%, on average.
Medifast, the manufacturer and distributor of weight loss, weight management, healthy living products, and other consumable health and nutritional products, currently carries a Zacks Rank #2. Shares of Medifast have risen 2.5% in the past three months.
The Zacks Consensus Estimate for Medifast’s current financial-year sales and EPS suggests growth of about 63% and 49.3%, respectively, from the year-ago reported figure. MED has a trailing four-quarter earnings surprise of 17.3%, on average.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report
 
Helen of Troy Limited (HELE): Free Stock Analysis Report
 
Nu Skin Enterprises, Inc. (NUS): Free Stock Analysis Report
 
MEDIFAST INC (MED): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413863

Wall Street has been suffering since the beginning of 2022 after finishing two successive impressive years despite being pandemic-ridden. In fact, severe volatility has gripped U.S. stock markets since Black Friday of 2021 with the resurgence of the Omicron variant of coronavirus and the Fed’s decision of a drastic shift from ultra-dovish monetary policies to a relatively hawkish stance.

– Zacks

Although, Fed Chairman Jerome Powell refrained from commenting anything on when the Fed will raise the benchmark lending rate and at what magnitude, Fed’s dot-plot indicates that all 18 members are expecting at least one rate hike in 2022. Of 18 Fed members, 12 expect three rate hikes in 2022 followed by two more in 2023 and 2024. Several analysts also warned that the Fed might hike rates as early as March.

The primary concern of the central bank is soaring inflation. The pandemic-led global disruption of the supply-chain system inflated input costs while growing demand is pulling up the general price level. In the United States, the consumer price index jumped to a 40-year high in December.

Several stocks have gained in the past four weeks. Notable among them are — Metropolitan Bank Holding Corp. MCB, Horizon Bancorp Inc. HBNC, CBIZ Inc. CBZ, Sensus Healthcare Inc. SRTS and Ocwen Financial Corp. OCN.

Here’s How We Arrived at the Picks

We have primarily targeted stocks that have freshly been on a bull run. Stocks seeing price strength recently have a high chance of carrying the momentum forward.
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here’s how you should create the screen to shortlist the current as well as the potential winners.

Screening Parameters:

Percentage Change in Price (4 Weeks) greater than zero: This criterion shows that the stock has moved higher in the last four weeks.
Percentage Change Price (12 Weeks) greater than 10: This indicates that the stock has seen momentum over the last three months. This lowers the risk of choosing stocks that may have drawn attention due to the overwhelming performance of the overall market in a very short period.
Zacks Rank 1: No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) have a proven history of outperformance. You can see the complete list of today’s Zacks #1 Rank stocks here.
Average Broker Rating 1 or 2: This indicates that brokers are also highly hopeful about the stock’s future performance.
Current Price greater than 5: The stocks must all be trading at a minimum of $5.
Current Price/ 52-Week High-Low Range more than 85%: This criterion filters stocks that are trading near their respective 52-week highs. It indicates that these are strong enough in terms of price.
Just these few criteria narrowed down the search from over 7,700 stocks to just 9.
Let’s discuss our five picks out of the 9 stocks:
Metropolitan Bank operates as the bank holding company for Metropolitan Commercial Bank that provides a range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area.

MCB offers deposits, small business lending, trade finance, cash management solutions, speciality markets, personal checking, savings, electronic banking and prepaid cards.

The stock price of Metropolitan Bank has climbed 17.7% in the past four weeks. MCB has an expected earnings growth rate of 10.7% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 7.1% over the last 60 days.

Horizon Bancorp operates as the bank holding company for Horizon Bank that provides a range of commercial and retail banking services. HBNC offers demand and time deposits. Horizon Bancorp also provides commercial, residential real estate, mortgage warehouse, and consumer loans.

In addition, HBNC offers corporate and individual trust and agency, investment management, and real estate investment trust services; and sells various insurance products.

The stock price of Horizon Bancorp has appreciated 16.2% in the past four weeks. HBNC has an expected earnings growth rate of 2% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3% over the last 30 days.

Sensus Healthcare manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. SRTS specializes in offering non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. Sensus Healthcare’s portfolio of treatment devices consists of the SRT-100 and SRT-100 Vision.

The stock price of SRTS has surged 15.7% in the past four weeks. Sensus Healthcare has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 7.7% over the last 30 days.

Ocwen Financial is a financial services holding company engaged in asset acquisition and resolution, residential finance, commercial finance, investment management and hotel operations. OCN primarily specializes in the acquisition and resolution of non-performing or underperforming loans.

Ocwen Financial operates in the United States, the United States Virgin Islands, India, and the Philippines. OCN has two operating segments — Servicing and Originations.

The stock price of Ocwen Financial has advanced 7.9% in the past four weeks. OCN has an expected earnings growth rate of 96.1% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 8.1% over the last 60 days.

CBIZ provides professional business services that help clients better manage their finances and employees. CBZ provides its clients with financial services including accounting, tax, financial advisory, government health care consulting, risk advisory, merger and acquisition advisory, real estate consulting, and valuation services.

CBIZ operates through three segments: Financial Services, Benefits and Insurance Services, and National Practices. CBZ is one of the nation’s largest brokers of employee benefits and property and casualty insurance, and one of the largest accounting and valuation companies in the United States

The stock price of CBIZ has gained 7.4% in the past four weeks. CBZ has an expected earnings growth rate of 13.7% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 5.3% over the last 7 days.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It’s easy to use. Everything is in plain language. And it’s very intuitive. Start your Research Wizard trial to day. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ocwen Financial Corporation (OCN): Free Stock Analysis Report
 
CBIZ, Inc. (CBZ): Free Stock Analysis Report
 
Horizon Bancorp IN (HBNC): Free Stock Analysis Report
 
Sensus Healthcare, Inc. (SRTS): Free Stock Analysis Report
 
Metropolitan Bank Holding Corp. (MCB): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413864

Celanese Corporation’s CE shares have gained 28.8% over the past year. The company has also outperformed its industry’s decline of 1.6% over the same time frame. It has also topped the S&P 500’s 23.7% rise over the same period.
Let’s dive into the factors behind this chemical maker’s stock price appreciation.

– Zacks

Image Source: Zacks Investment Research

 

What’s Favoring CE?

Celanese, a Zacks Rank #3 (Hold) stock, is benefiting from its cost and productivity actions, investments in high-return organic projects and synergies of acquisitions. The company is also gaining from higher demand in most of its end markets.
The company, in its third-quarter call, stated that demand for its products remains strong in most end markets as it enters the fourth quarter. It sees pent-up demand across Engineered Materials and Acetyl Chain units to more than offset any impact of typical year-end seasonality. Notwithstanding the sourcing and logistics headwinds, the company expects to deliver fourth-quarter adjusted earnings of roughly $5.00 per share.
The company also continues to actively pursue acquisitions, which are providing it opportunities for additional growth, investment and synergies. The acquisitions of SO.F.TER., Nilit and Omni Plastics are expected to contribute to earnings expansion in the company’s Engineered Materials segment. The Elotex acquisition also strengthened the company’s position in the vinyl acetate ethylene emulsions space. The buyout is expected to contribute to volumes in the Acetyl Chain segment.
The recently completed purchase of Exxon Mobil’s Santoprene business also broadens the company’s portfolio of engineered solutions and enables it to offer a wider range of functionalized solutions to targeted growth areas, including future mobility, medical and sustainability. Celanese expects the acquisition to be immediately accretive to its 2022 adjusted earnings per share and free cash flow.
Celanese also remains focused on executing its productivity programs that include the implementation of a number of cost reduction capital projects. Productivity actions are expected to support to its margins.
The company also continues to generate strong cash flows and is focused on boosting shareholders’ value. It returned $376 million to shareholders through dividend payouts and share repurchases during the third quarter of 2021. The company expects to generate more than $1.2 billion in free cash flows for full-year 2021.

Stocks to Consider

Better-ranked stocks worth considering in the basic materials space include Commercial Metals Company CMC, Albemarle Corporation ALB and AdvanSix Inc. ASIX, each sporting a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
 
Commercial Metals has a projected earnings growth rate of 10.5% for the current fiscal year. The Zacks Consensus Estimate for CMC’s current fiscal year earnings has been revised 6.6% upward over the past 60 days.
Commercial Metals beat the Zacks Consensus Estimate for earnings in three of the last four quarters while missed once. It has a trailing four-quarter earnings surprise of roughly 7.4%, on average. CMC has rallied around 72% in a year.
Albemarle has an expected earnings growth rate of 51.3% for the current year. ALB’s consensus estimate for the current year has been revised 5.4% upward over the past 60 days.
Albemarle beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 22.1%. ALB shares have gained around 26% over the past year.
AdvanSix has an expected earnings growth rate of 3.9% for the current year. The Zacks Consensus Estimate for ASIX’s current-year earnings has been revised 2% upward in the past 60 days.
AdvanSix beat the Zacks Consensus Estimate for earnings in each of the trailing four quarters, the average being 46.9%. ASIX has rallied around 97% in a year.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Albemarle Corporation (ALB): Free Stock Analysis Report
 
Celanese Corporation (CE): Free Stock Analysis Report
 
Commercial Metals Company (CMC): Free Stock Analysis Report
 
AdvanSix (ASIX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413865

Here are three stocks with buy rank and strong income characteristics for investors to consider today, January 19th:

– Zacks

Ready Capital Corp RC: This publicly-traded mortgage REIT has witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 3% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 10.84%, compared with the industry average of 7.82%.

Lumen Technologies LUMN: This leading rural local exchange carrier providing a range of telecom services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 8.10%, compared with the industry average of 0.00%.

PetroChina PTR: This largest integrated oil company in China has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 7.07%, compared with the industry average of 4.06%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PetroChina Company Limited (PTR): Free Stock Analysis Report
 
Ready Capital Corp (RC): Free Stock Analysis Report
 
Lumen Technologies, Inc. (LUMN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413866

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 19th:

– Zacks

PetroChina PTR: This largest integrated oil company in China has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.

PetroChina’s shares gained 18.0% over the last one month compared with the S&P 500’s growth of 1.8%. The company possesses a Momentum Score of A.

Taiwan Semiconductor TSM: This world’s largest dedicated integrated circuit foundry has a Zacks Rank and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.

Taiwan Semiconductor’s shares gained 16.4% over the last one month compared with the S&P 500’s growth of 1.8%. The company possesses a Momentum Score of A.

Crescent Point Energy CPG: This company which is engaged in the acquisition, exploration and development of oil and natural gas properties in Western Canada has a Zacks Rank and witnessed the Zacks Consensus Estimate for its current quarter earnings increasing 20.8% over the last 60 days.

Crescent Point Energy’s shares gained 48.5% over the last one month compared with the S&P 500’s growth of 1.8%. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PetroChina Company Limited (PTR): Free Stock Analysis Report
 
Taiwan Semiconductor Manufacturing Company Ltd. (TSM): Free Stock Analysis Report
 
Crescent Point Energy Corporation (CPG): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413858

Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 19th:

– Zacks

Air Transport Services Group ATSG: This leading provider of aircraft leasing, and air cargo transportation carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 1.1% over the last 60 days.

Air Transport Services has a price-to-earnings ratio (P/E) of 15.09, compared with 22.00 for the industry. The company possesses a Value Score of A.

PetroChina PTR: This largest integrated oil company in China carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.

PetroChina has a price-to-earnings ratio (P/E) of 6.36, compared with 9.30 for the industry. The company possesses a Value Score of A.

Lumen Technologies LUMN: This leading rural local exchange carrier providing a range of telecom services carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

Lumen Technologies has a price-to-earnings ratio (P/E) of 8.10, compared with 37.00 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
PetroChina Company Limited (PTR): Free Stock Analysis Report
 
Air Transport Services Group, Inc (ATSG): Free Stock Analysis Report
 
Lumen Technologies, Inc. (LUMN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413859

Onto Innovation (ONTO) shares soared 11.4% in the last trading session to close at $105.96. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock’s 4.6% gain over the past four weeks.

– Zacks

ONTO’s rally is largely driven by optimism over solid market response for its cost-effective solutions. This avant-garde process control tools manufacturer recently announced a total order backlog of $500 million. The order backlog includes $100 million for lithography and inspection products, which are witnessing high demand in the fast-growing heterogeneous packaging sector. The company is also witnessing strong demand for its Dragon G3 Inspection system.
It has secured orders worth $12 million for the Dragon G3 Inspection system. Further, healthy projections of heterogeneous packaging within the packaging market bode well for Onto Innovation, one of the leading players in the semiconductor equipment industry. Given the robust demand environment for both front-end and back-end products with their increased adoption, it expects revenues in the range of $210-$220 million compared with the prior-guided range of $190-$200 million for the fourth quarter of 2021.

This maker of semiconductor manufacturing equipment is expected to post quarterly earnings of $1.10 per share in its upcoming report, which represents a year-over-year change of +52.8%. Revenues are expected to be $214.9 million, up 38.5% from the year-ago quarter.

While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For Onto Innovation, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock’s price usually doesn’t keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on ONTO going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>

Just Released: Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?

From inception in 2012 through 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% versus the S&P 500’s +348.7%. Now our Director of Research has combed through 4,000 companies covered by the Zacks Rank and has handpicked the best 10 tickers to buy and hold. Don’t miss your chance to get in…because the sooner you do, the more upside you stand to grab.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Onto Innovation Inc. (ONTO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

https://www.entrepreneur.com/article/413644